about
Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic reviewDiagnosing and managing diabetes in HIV-infected patients: current conceptsConsensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetesThe future of population registers: linking routine health datasets to assess a population's current glycaemic status for quality improvementCardiometabolic risk factors, metabolic syndrome and pre-diabetes in adolescents in the Sierra region of Ecuador.Usefulness of a novel system for measuring glucose area under the curve while screening for glucose intolerance in outpatients.Prediabetes: The Variation between HbA1c and Fasting Plasma Glucose.Using hemoglobin A1C as a predicting model for time interval from pre-diabetes progressing to diabetes.Diabetes and pre-diabetes as determined by glycated haemoglobin A1c and glucose levels in a developing southern Chinese population.Prevalence of insulin resistance in siblings of type 2 diabetics of north west punjabi population.Impact of implementing glycated hemoglobin testing for identification of dysglycemia in youth.The reliability of in-hospital diagnoses of diabetes mellitus in the setting of an acute myocardial infarctionThe prevalence and determinants of undiagnosed and diagnosed type 2 diabetes in middle-aged irish adultsA randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy.A case of inappropriately high glycated hemoglobin.Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study.HbA1c alone is a poor indicator of cardiometabolic risk in middle-aged subjects with pre-diabetes but is suitable for type 2 diabetes diagnosis: a cross-sectional study.Implications of iron deficiency/anemia on the classification of diabetes using HbA1cSalivary protein glycosylation as a noninvasive biomarker for assessment of glycemia.Group Medical Visits (GMVs) in primary care: an RCT of group-based versus individual appointments to reduce HbA1c in older peopleThe Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-AnalysisThe Relationship between Dietary Patterns and Metabolic Health in a Representative Sample of Adult Australians.Diabetes prevention: global health policy and perspectives from the ground.Burden of Diabetes and First Evidence for the Utility of HbA1c for Diagnosis and Detection of Diabetes in Urban Black South Africans: The Durban Diabetes Study.The Impact of HbA1c Testing on Total Annual Healthcare Expenditures Among Newly Diagnosed Patients with Diabetes.The long and winding road to optimal HbA1c measurement.No ethnic differences in the association of glycated hemoglobin with retinopathy: the national health and nutrition examination survey 2005-2008.Increases in blood glucose in older adults: the effects of spousal health.Prediabetes, undiagnosed diabetes, and diabetes among Mexican adults: findings from the Mexican Health and Aging Study.The Diabetic Health of African American Grandmothers Raising their GrandchildrenOptimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population.Diabetic Profile- Screening of HBA1C - A Random Community AssessmentHbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?PERFORMANCE OF A1C VERSUS OGTT FOR THE DIAGNOSIS OF PREDIABETES IN A COMMUNITY-BASED SCREENING.The dynamics of diabetes among birth cohorts in the U.S.Restorative yoga and metabolic risk factors: the Practicing Restorative Yoga vs. Stretching for the Metabolic Syndrome (PRYSMS) randomized trial.The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention.Glucokinase MODY and implications for treatment goals of common forms of diabetes.Hyperglycemia at presentation is associated with in hospital mortality in non-diabetic patient with organophosphate poisoning.Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.
P2860
Q24618259-4DE205C5-E69E-48F2-801D-A32744FCD8B4Q27014697-9FC8FB08-CDDD-49ED-8E5B-EFA1C67F1B20Q28732681-352A8301-4073-4FB5-AA43-FFB4D6701A24Q33569607-0496C9E2-AA6B-4375-AF09-94AD5F0D3104Q33582590-362B12F3-A620-4381-8847-F7E75F619A0CQ33607725-781996A7-D881-4A19-BFC8-B703EA8F2C1BQ33768831-D2B87DF1-2489-433A-9656-672A4658FA20Q34004933-8F494FA4-14AE-48F3-AC85-0D2931437FA4Q34277912-988E461B-CEE1-4E48-B26B-B637F3050DDAQ34310570-ACB5C8FD-171B-4585-A81F-9E3B23D2BCA5Q34386652-C906A1FF-28D2-4EAC-BDD3-63C0C0191968Q34564126-EDBB6C75-39D5-4D20-8396-5879C6138259Q35055136-8B332C25-D73A-41F1-A0A2-3C05DF6B017FQ35102138-0ACD56AC-2BDA-47D4-85D9-7FD2ED0132D2Q35365676-BE09194C-F12D-442B-B4B4-B9BB4D65285FQ35671852-B6E1B2BA-6EFE-48E2-B233-79AE42873487Q35743645-FEF66EB4-8A96-4E0D-87FF-E161B14BC0A6Q35819187-D8A81369-2FFB-48E8-A333-A86F2F50DD04Q35830450-D3D1387B-371A-4E37-8697-61CCF217429DQ35884897-CB4B2A22-C290-4066-8C5C-33AF002ED280Q36001658-CDDFDEA4-EF9D-400B-875B-E52E61212B25Q36012400-52315D7F-22BD-40A0-8FA8-CAE4B936032AQ36016845-0DECA4F8-7647-4774-B16A-A2A61F32262DQ36112955-0F4C44FB-77E7-4954-AADE-76182305F2FAQ36257570-BE06F575-1E8A-468C-A880-56FD87830C04Q36603290-154DCB8F-CF75-4055-9B2E-6DE2D6F1D48AQ36629498-C7787ACA-D391-4FC8-80AA-3DDF7F971E1CQ36692338-A9EF9B2B-31C1-4131-B123-FDFF821548AAQ36890821-6036A891-AC8C-4CC2-99C0-63F63D009BD9Q37052239-A6A998A1-7639-4401-92A0-631FDC6136E5Q37342171-E719DEE3-A59B-4D75-A675-1FFECB650996Q37349917-6309504E-1074-4BC8-922E-27E6283BA8DBQ37359624-F787BB1B-A96B-4D54-8A88-C358525F71BCQ37613221-72DDF749-B2DF-461E-8E38-83B5D75EC1EFQ37660898-4ADB70C1-A197-4079-B64B-5B264C2C6ECAQ37732322-8938B63F-70A7-4990-A5AB-D5DBBDA086A2Q38061853-E8308EF3-3B6C-45BF-BA50-397E348A7A6CQ38262676-86A269F6-520E-4A84-950F-9597164F8CC3Q38418242-69A02C87-0C8A-46FD-BD8C-9E18BFE45E23Q38445925-B0545381-CE04-47D8-9B45-E43308BF5E5D
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The pros and cons of diagnosing diabetes with A1C
@en
type
label
The pros and cons of diagnosing diabetes with A1C
@en
prefLabel
The pros and cons of diagnosing diabetes with A1C
@en
P2860
P356
P1433
P1476
The pros and cons of diagnosing diabetes with A1C
@en
P2860
P304
P356
10.2337/DC11-S216
P407
P478
34 Suppl 2
P577
2011-05-01T00:00:00Z